Could glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide — approved as Ozempic to treat type 2 diabetes and as Wegovy to treat obesity, also
Substantial reductions in body weight across body mass index (BMI) categories, as well as improved body composition, were achieved with tirzepatide (Mounjaro) in adults for
A new guideline from the World Health Organization (WHO) on nonsugar sweeteners (NSSs) recommends not using them to control weight or to reduce the risk
A survey has suggested that more than 8 in 10 people (84%) people affected by eating disorders believe the introduction of calories on menus has
New research has revealed that taking short breaks from sitting can help people with Type 1 diabetes better manage their blood sugar levels. Sitting for
A study has been conducted to explore the possible association between vitamin B12 deficiency and gastroparesis in patients with Type 2 diabetes. Diabetic gastroparesis is
According to DiaTribe Learn, Novo Nordisk has released initial results for a clinical trial testing Rybelsus at high doses, showing significant reductions in both HbA1c
Soft drinks are considered as drivers for obesity and Type 2 diabetes, but little progress is being made in reducing sugar in soft drinks. From
A new observational study has found that consumption of a low-carbohydrate, high-fat diet (dubbed a ‘keto-like’ diet), was associated with an increase in LDL levels
According to planet and environment news site www.earth.com, moderate to high consumption of black, green, or Oolong tea is associated with a lower risk of
